Home/Filings/4/0001572426-17-000018
4//SEC Filing

Brown Christopher Nigel 4

Accession 0001572426-17-000018

CIK 0001618561other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 9:18 PM ET

Size

11.9 KB

Accession

0001572426-17-000018

Insider Transaction Report

Form 4
Period: 2017-07-31
Transactions
  • Disposition to Issuer

    Ordinary Shares

    2017-07-31$6.72/sh7,200$48,3840 total
  • Disposition to Issuer

    Options to purchase ordinary shares

    2017-07-31$6.59/sh7,080$46,6930 total
    Exercise: $0.13Exp: 2020-11-05Ordinary Shares (7,080 underlying)
  • Disposition to Issuer

    Options to purchase ordinary shares

    2017-07-31$6.59/sh3,600$23,7420 total
    Exercise: $0.13Exp: 2019-07-01Ordinary Shares (3,600 underlying)
  • Disposition to Issuer

    Ordinary Shares

    2017-07-31$6.72/sh8,800$59,1360 total(indirect: Elsing Pty Ltd.)
Footnotes (4)
  • [F1]Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer.
  • [F2]The reporting person has sole voting and dispositive power with respect to these reported securities.
  • [F3]This option, which was fully vested, was cancelled in the Acquisition in exchange for a cash payment equal to $23,742.00, representing the difference between the exercise price of $0.125 per share and the $6.72 consideration per share payable in connection with in the Acquisition multiplied by the number of shares issuable on exercise of the option.
  • [F4]This option, which was fully vested, was cancelled in the Acquisition in exchange for a cash payment equal to $46,692.60, representing the difference between the exercise price of $0.125 per share and the $6.72 consideration per share payable in connection with in the Acquisition multiplied by the number of shares issuable on exercise of the option.

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeother

Related Parties

1
  • filerCIK 0001632388

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:18 PM ET
Size
11.9 KB